
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (34): 5071-5077.DOI: 10.12114/j.issn.1007-9572.2025.0340
• Article • Previous Articles
Received:2025-10-28
Revised:2026-05-13
Published:2026-12-05
Online:2026-10-26
Contact:
GAO Aiju
通讯作者:
高爱菊
作者简介:作者贡献:
李金婷提出研究思路,设计研究方案,负责数据的统计分析与文章撰写;高爱菊负责最终版本修订,对论文整体负责。
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2025.0340
| 变量 | Q1组(n=1 866) | Q2组(n=1 866) | Q3组(n=1 866) | Q4组(n=1 866) | H(χ2)值 | P值 |
|---|---|---|---|---|---|---|
| 年龄[M(P25,P75),岁] | 56(49,62) | 56(49,63) | 58(51,64) | 62(56,69) | 481.220 | <0.001 |
| 性别(男/女) | 1 334/532 | 1 217/649 | 963/903 | 480/1 386 | 927.200a | <0.001 |
| 同居[名(%)] | 292(15.65) | 319(17.10) | 353(18.92) | 350(18.76) | 9.181a | 0.030 |
| 已婚[名(%)] | 340(18.22) | 363(19.45) | 393(21.06) | 408(21.86) | 9.253a | 0.030 |
| 大学及以上[名(%)] | 325(17.42) | 307(16.45) | 232(12.43) | 116(6.22) | 235.210a | <0.001 |
| 目前吸烟[名(%)] | 1 028(55.09) | 922(49.41) | 767(41.10) | 431(23.10) | 447.050a | <0.001 |
| 目前饮酒[名(%)] | 209(11.20) | 177(9.49) | 137(7.34) | 99(5.31) | 48.119a | <0.001 |
| 高血压[名(%)] | 505(27.06) | 689(36.92) | 775(41.53) | 983(52.68) | 264.690a | <0.001 |
| 糖尿病[名(%)] | 49(2.63) | 74(3.97) | 103(5.52) | 141(7.56) | 53.815a | <0.001 |
| 血脂异常[名(%)] | 119(6.38) | 139(7.45) | 176(9.43) | 198(10.61) | 26.317a | <0.001 |
| 服用抗抑郁药[名(%)] | 7(0.38) | 20(1.07) | 16(0.86) | 29(1.55) | 13.998a | 0.003 |
| 收缩压[M(P25,P75),mmHg] | 123(112,136) | 126(115,141) | 1 297(116,142) | 134(119,149) | 237.460 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 74(66,82) | 76(68,84) | 76(69,84) | 76(69,85) | 51.040 | <0.001 |
| BMI[M(P25,P75),kg/m2] | 21.8(20.0,23.8) | 23.2(21.1,25.4) | 24.0(21.5,26.5) | 24.6(22.1,27.4) | 580.280 | <0.001 |
| FPG[M(P25,P75),mg/dL] | 99.5(92.9,108.5) | 102.2(94.0,112.9) | 104.2(95.9,115.7) | 104.8(96.1,117.9) | 114.630 | <0.001 |
| TC[M(P25,P75),mg/dL] | 182.48(160.44,207.99) | 189.05(167.40,211.08) | 192.91(169.72,216.50) | 195.43(172.81,221.91) | 96.907 | <0.001 |
| TG[M(P25,P75),mg/dL] | 89.39(64.61,131.87) | 103.55(73.46,148.68) | 110.63(79.65,164.61) | 118.59(83.19,181.43) | 215.880 | <0.001 |
| LDL-C[M(P25,P75),mg/dL] | 110.18(90.46,130.09) | 113.85(93.17,134.15) | 115.21(93.17,138.4) | 118.49(95.88,143.04) | 48.243 | <0.001 |
| HDL-C[M(P25,P75),mg/dL] | 52.19(43.30,61.86) | 49.48(40.21,60.31) | 47.55(38.66,57.60) | 46.78(38.66,57.02) | 100.880 | <0.001 |
| CRP[M(P25,P75),mg/dL] | 0.79(0.45,1.60) | 0.92(0.53,1.87) | 1.14(0.60,2.19) | 1.34(0.69,2.72) | 160.430 | <0.001 |
| eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | 96.24(86.62,103.22) | 95.33(84.86,103.59) | 94.37(83.29,101.78) | 91.15(79.81,99.42) | 115.630 | <0.001 |
Table 1 Comparison of baseline characteristics among middle-aged and older adults across WWI quartile groups
| 变量 | Q1组(n=1 866) | Q2组(n=1 866) | Q3组(n=1 866) | Q4组(n=1 866) | H(χ2)值 | P值 |
|---|---|---|---|---|---|---|
| 年龄[M(P25,P75),岁] | 56(49,62) | 56(49,63) | 58(51,64) | 62(56,69) | 481.220 | <0.001 |
| 性别(男/女) | 1 334/532 | 1 217/649 | 963/903 | 480/1 386 | 927.200a | <0.001 |
| 同居[名(%)] | 292(15.65) | 319(17.10) | 353(18.92) | 350(18.76) | 9.181a | 0.030 |
| 已婚[名(%)] | 340(18.22) | 363(19.45) | 393(21.06) | 408(21.86) | 9.253a | 0.030 |
| 大学及以上[名(%)] | 325(17.42) | 307(16.45) | 232(12.43) | 116(6.22) | 235.210a | <0.001 |
| 目前吸烟[名(%)] | 1 028(55.09) | 922(49.41) | 767(41.10) | 431(23.10) | 447.050a | <0.001 |
| 目前饮酒[名(%)] | 209(11.20) | 177(9.49) | 137(7.34) | 99(5.31) | 48.119a | <0.001 |
| 高血压[名(%)] | 505(27.06) | 689(36.92) | 775(41.53) | 983(52.68) | 264.690a | <0.001 |
| 糖尿病[名(%)] | 49(2.63) | 74(3.97) | 103(5.52) | 141(7.56) | 53.815a | <0.001 |
| 血脂异常[名(%)] | 119(6.38) | 139(7.45) | 176(9.43) | 198(10.61) | 26.317a | <0.001 |
| 服用抗抑郁药[名(%)] | 7(0.38) | 20(1.07) | 16(0.86) | 29(1.55) | 13.998a | 0.003 |
| 收缩压[M(P25,P75),mmHg] | 123(112,136) | 126(115,141) | 1 297(116,142) | 134(119,149) | 237.460 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 74(66,82) | 76(68,84) | 76(69,84) | 76(69,85) | 51.040 | <0.001 |
| BMI[M(P25,P75),kg/m2] | 21.8(20.0,23.8) | 23.2(21.1,25.4) | 24.0(21.5,26.5) | 24.6(22.1,27.4) | 580.280 | <0.001 |
| FPG[M(P25,P75),mg/dL] | 99.5(92.9,108.5) | 102.2(94.0,112.9) | 104.2(95.9,115.7) | 104.8(96.1,117.9) | 114.630 | <0.001 |
| TC[M(P25,P75),mg/dL] | 182.48(160.44,207.99) | 189.05(167.40,211.08) | 192.91(169.72,216.50) | 195.43(172.81,221.91) | 96.907 | <0.001 |
| TG[M(P25,P75),mg/dL] | 89.39(64.61,131.87) | 103.55(73.46,148.68) | 110.63(79.65,164.61) | 118.59(83.19,181.43) | 215.880 | <0.001 |
| LDL-C[M(P25,P75),mg/dL] | 110.18(90.46,130.09) | 113.85(93.17,134.15) | 115.21(93.17,138.4) | 118.49(95.88,143.04) | 48.243 | <0.001 |
| HDL-C[M(P25,P75),mg/dL] | 52.19(43.30,61.86) | 49.48(40.21,60.31) | 47.55(38.66,57.60) | 46.78(38.66,57.02) | 100.880 | <0.001 |
| CRP[M(P25,P75),mg/dL] | 0.79(0.45,1.60) | 0.92(0.53,1.87) | 1.14(0.60,2.19) | 1.34(0.69,2.72) | 160.430 | <0.001 |
| eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | 96.24(86.62,103.22) | 95.33(84.86,103.59) | 94.37(83.29,101.78) | 91.15(79.81,99.42) | 115.630 | <0.001 |
| 模型 | WWI四分位数分组(以Q1组为参照) | WWI(以实测值纳入) | 趋势检验P值 | ||
|---|---|---|---|---|---|
| Q2组 | Q3组 | Q4组 | |||
| 模型1 | 1.00(0.88~1.14) | 1.09(0.96~1.24) | 1.30(1.14~1.48) | 1.04(1.00~1.08) | <0.001 |
| 模型2 | 1.00(0.88~1.14) | 1.09(0.95~1.24) | 1.32(1.15~1.52) | 1.04(1.00~1.08) | <0.001 |
| 模型3 | 0.90(0.77~1.05) | 1.02(0.84~1.18) | 1.23(1.05~1.44) | 1.02(1.00~1.04) | 0.006 |
Table 2 Logistic regression analysis of the association between WWI and incident depressive symptoms
| 模型 | WWI四分位数分组(以Q1组为参照) | WWI(以实测值纳入) | 趋势检验P值 | ||
|---|---|---|---|---|---|
| Q2组 | Q3组 | Q4组 | |||
| 模型1 | 1.00(0.88~1.14) | 1.09(0.96~1.24) | 1.30(1.14~1.48) | 1.04(1.00~1.08) | <0.001 |
| 模型2 | 1.00(0.88~1.14) | 1.09(0.95~1.24) | 1.32(1.15~1.52) | 1.04(1.00~1.08) | <0.001 |
| 模型3 | 0.90(0.77~1.05) | 1.02(0.84~1.18) | 1.23(1.05~1.44) | 1.02(1.00~1.04) | 0.006 |
| 亚组 | WWI四分位数分组(以Q1组为参照) | WWI (以实测值纳入) | P交互值 | ||
|---|---|---|---|---|---|
| Q2组 | Q3组 | Q4组 | |||
| 年龄 | <0.01 | ||||
| <65岁 | 1.00(0.86~1.15) | 1.11(0.96~1.29) | 1.46(1.24~1.73) | 1.05(1.00~1.09) | |
| ≥65岁 | 0.95(0.70~1.30) | 0.84(0.63~1.14) | 0.89(0.67~1.19) | 0.99(0.92~1.06) | |
| 性别 | 0.77 | ||||
| 男 | 1.00(0.85~1.17) | 0.96(0.81~1.14) | 1.11(0.89~1.39) | 1.00(0.94~1.05) | |
| 女 | 0.94(0.74~1.19) | 1.04(0.83~1.29) | 1.11(0.89~1.38) | 1.01(0.96~1.07) | |
| BMI | 0.81 | ||||
| <28.0 kg/m2 | 0.99(0.86~1.13) | 1.06(0.92~1.22) | 1.26(1.08~1.47) | 1.03(0.99~1.07) | |
| ≥28.0 kg/m2 | 1.28(0.76~2.15) | 1.25(0.77~2.02) | 1.56(0.97~2.51) | 1.06(0.97~1.15) | |
| 目前吸烟 | 0.19 | ||||
| 否 | 1.00(0.83~1.21) | 1.20(1.00~1.44) | 1.34(1.12~1.61) | 1.05(1.00~1.10) | |
| 是 | 0.99(0.82~1.18) | 0.90(0.74~1.09) | 1.21(0.96~1.54) | 0.99(0.94~1.05) | |
| 目前饮酒 | 0.39 | ||||
| 否 | 1.01(0.88~1.15) | 1.09(0.95~1.26) | 1.26(1.09~1.46) | 1.03(0.99~1.07) | |
| 是 | 1.01(0.67~1.53) | 0.84(0.53~1.32) | 1.60(0.94~2.74) | 1.03(0.92~1.15) | |
Table 3 Subgroup analysis of Logistic regression on the association between WWI and incident depressive symptoms
| 亚组 | WWI四分位数分组(以Q1组为参照) | WWI (以实测值纳入) | P交互值 | ||
|---|---|---|---|---|---|
| Q2组 | Q3组 | Q4组 | |||
| 年龄 | <0.01 | ||||
| <65岁 | 1.00(0.86~1.15) | 1.11(0.96~1.29) | 1.46(1.24~1.73) | 1.05(1.00~1.09) | |
| ≥65岁 | 0.95(0.70~1.30) | 0.84(0.63~1.14) | 0.89(0.67~1.19) | 0.99(0.92~1.06) | |
| 性别 | 0.77 | ||||
| 男 | 1.00(0.85~1.17) | 0.96(0.81~1.14) | 1.11(0.89~1.39) | 1.00(0.94~1.05) | |
| 女 | 0.94(0.74~1.19) | 1.04(0.83~1.29) | 1.11(0.89~1.38) | 1.01(0.96~1.07) | |
| BMI | 0.81 | ||||
| <28.0 kg/m2 | 0.99(0.86~1.13) | 1.06(0.92~1.22) | 1.26(1.08~1.47) | 1.03(0.99~1.07) | |
| ≥28.0 kg/m2 | 1.28(0.76~2.15) | 1.25(0.77~2.02) | 1.56(0.97~2.51) | 1.06(0.97~1.15) | |
| 目前吸烟 | 0.19 | ||||
| 否 | 1.00(0.83~1.21) | 1.20(1.00~1.44) | 1.34(1.12~1.61) | 1.05(1.00~1.10) | |
| 是 | 0.99(0.82~1.18) | 0.90(0.74~1.09) | 1.21(0.96~1.54) | 0.99(0.94~1.05) | |
| 目前饮酒 | 0.39 | ||||
| 否 | 1.01(0.88~1.15) | 1.09(0.95~1.26) | 1.26(1.09~1.46) | 1.03(0.99~1.07) | |
| 是 | 1.01(0.67~1.53) | 0.84(0.53~1.32) | 1.60(0.94~2.74) | 1.03(0.92~1.15) | |
| [1] |
王越,陈晴,刘鲁蓉. 中国老年人抑郁检出率及影响因素的Meta分析[J]. 中国全科医学, 2023, 26(34): 4329-4335. DOI: 10.12114/j.issn.1007-9572.2023.0269.
|
| [2] | |
| [3] |
段丽敏,袁媛,赵强,等. 基于"郁病相生理论"探析慢性胃炎伴焦虑抑郁状态病机与治则[J]. 陕西中医, 2025, 46(6): 800-804. DOI: 10.3969/j.issn.1000-7369.2025.06.016.
|
| [4] |
郭成. 抑郁症状在共病老年人社会参与与认知功能间的中介效应[J]. 中国健康心理学杂志, 2025, 33(3): 321-326. DOI: 10.13342/j.cnki.cjhp.2025.03.001.
|
| [5] |
祝春素,连至炜,崔一民. 中国中老年人抑郁和慢性病的关联[J]. 北京大学学报(医学版), 2023, 55(4): 606-611. DOI: 10.19723/j.issn.1671-167X.2023.04.006.
|
| [6] |
郝萌萱,尹孟凡,夏笑清,等. 1990年与2019年中国人群抑郁症疾病负担分析[J]. 中国慢性病预防与控制, 2022, 30(8): 623-625. DOI: 10.16386/j.cjpccd.issn.1004-6194.2022.08.014.
|
| [7] |
张鑫,刘志芬,郭云童. 肥胖与抑郁症相关性的研究进展[J]. 中华肥胖与代谢病电子杂志, 2024, 10(4): 255-260. DOI: 10.3877/cma.j.issn.2095-9605.2024.04.005.
|
| [8] |
|
| [9] |
|
| [10] |
傅联聪,赵海丰. 肥胖与抑郁的关联机制研究进展[J]. 世界最新医学信息文摘, 2019, 19(80): 148-149, 151. DOI: 10.19613/j.cnki.1671-3141.2019.80.068.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
曹睿,张越洋,李沛东,等. 体重调整腰围指数与新发脑卒中的关系:一项追踪10年的研究[J]. 中国医学前沿杂志(电子版), 2025, 17(1): 49-55. DOI: 10.12037/YXQY.2025.01-08.
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
中华人民共和国国家卫生健康委员会医政司. 肥胖症中国诊疗指南(2024年版)[J]. 协和医学杂志, 2025, 16(1): 90-108. DOI: 10.12290/xhyxzz.2024-0918.
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [1] | LI Jixin, QIU Linjie, REN Yan, LI Meijie, ZOU Chacha, WU Zijing, WANG Wenru, YANG Zhenyu, LIU Fengzhao, ZHANG Jin. Study on the Correlation between Phase Angle and Abnormal Glucose and Lipid Metabolism in Overweight/Obese Patients and Its Predictive Value [J]. Chinese General Practice, 2026, 29(33): 4876-4884. |
| [2] | LI Zihan, LIU Lei, WANG Jiayu, ZHU Xinyu, TIAN Yu. Research Progress on the Application of Virtual Reality Technology in the Management of Childhood and Adolescent Obesity [J]. Chinese General Practice, 2026, 29(33): 4943-4950. |
| [3] | HU Ruomeng, LIU Zhidong, CHEN Junlan, WANG Miao, ZHOU Shigao. Multicenter, Double Blind, Randomized, Controlled Study on Metabolic Formula Combined with Metformin Intervening Type 2 Diabetes Patients with Obesity [J]. Chinese General Practice, 2026, 29(33): 4854-4860. |
| [4] | WANG Zhongkai, WU Changyong, LI Menghan, LUO Yihua, ZHANG Bingqing, PENG Yunzhu. Association between Remnant Cholesterol Inflammatory Index and Risk of Cardiometabolic Multimorbidity in Middle-aged and Older Adults [J]. Chinese General Practice, 2026, 29(31): 4573-4581. |
| [5] | YANG Caiyi, HU Xiaohai, ZHU Hongjun, XU Yifan. Therapeutic Effect of Chaigu Decoction Combined with Western Medicine on Hypertension with Liver Depression and Blood Deficiency Pattern and Its Serum Metabolomics Analysis [J]. Chinese General Practice, 2026, 29(31): 4589-4599. |
| [6] | ZHANG Shuaishuai, CHEN Yue, QIU Jiaojiao, ZHU Ping, WANG Shuxia. Association between Remnant Cholesterol Inflammatory Index and Biological Age Acceleration in Middle-aged and Older Chinese Adults: a Nationwide Cohort Study [J]. Chinese General Practice, 2026, 29(30): 4397-4405. |
| [7] | LI Lan, LIU Lidi, ZHANG Peng, LI Dongze, YANG Ziyu, CHENG Yonglang, LIAO Xiaoyang, WAN Zhi. Lifestyle Intervention-based Weight Management: an Analysis of Key Highlights from the Partial Update of the 2025 NICE Guideline Overweight and Obesity Management (NG246) [J]. Chinese General Practice, 2026, 29(30): 4353-4359. |
| [8] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [9] | WANG Shuaihang, CAO Yedi, CHEN Fei, ZHU Sainan, GAO Ying. The Association between the Weight-adjusted Waist Index and Thyroid Function and Autoimmunity: Insights from NHANES Data [J]. Chinese General Practice, 2026, 29(30): 4406-4414. |
| [10] | ZHANG Han, CAI Genshen, FENG Zhengwen, ZHANG Kaiyue, LIAN Dongbo, ZHANG Hua, ZHANG Jing. Evaluating the Availability of Health Services for Obesity Comorbidities under Hierarchical Diagnosis and Treatment in Beijing: a Healthcare Institution Survey Study [J]. Chinese General Practice, 2026, 29(28): 4117-4124. |
| [11] | FU Xiaoya, YANG Fei, GU Keyi, GU Handong, WANG Weiqiang. Correlation between Relative Fat Mass Index and Decreased Glomerular Filtration Rate in Patients with Cardiometabolic Comorbidities [J]. Chinese General Practice, 2026, 29(28): 4187-4192. |
| [12] | ZHANG Ying, TANG Yijun, LIU Lidi, JIANG Lihua, JIA Yu, YANG Rong, YANG Ziyu, LIAO Xiaoyang. Management of Cardiovascular Metabolic Risks in Obese Children and Adolescents in China: Based on the 2024 Italian Society of Pediatric Endocrinology and Diabetes Position Paper on Cardiometabolic Risk in Children and Adolescents with Obesity [J]. Chinese General Practice, 2026, 29(27): 3879-3887. |
| [13] | XU Xiliang, LIU Mingfan, CHENG Guo, YANG Lihao. Study on the Relationship between Negative Attention Bias, Interpretation Bias and Depression in College Students [J]. Chinese General Practice, 2026, 29(24): 3486-3492. |
| [14] | Expert Group on Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China, Professional Committee on Obesity Control in Women and Children, China Maternal and Child Health Research Association. Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China (Second Edition) [J]. Chinese General Practice, 2026, 29(23): 3233-3252. |
| [15] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||